The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6,7-substituted-5,8-QUINOLINEQUINONE (cas 10470-83-4)s

Add time:07/31/2019    Source:sciencedirect.com

A variety of 6,7-substituted-5,8-quinolinequinones were synthesised and assessed for their anti-tumour and anti-inflammatory activities, and their ability to inhibit the growth of Mycobacterium bovis BCG. In particular, the introduction of a sulfur group at the 7-position of the quinolinequinone led to the discovery of two compounds, 6-methylamino-7-methylsulfanyl-5,8-quinolinequinone (10a) and 6-amino-7-methylsulfonyl-5,8-quinolinequinone (12), that exhibited selectivity for leukemic cells over T-cells, a highly desirable property for an anti-cancer drug. A number of anti-inflammatory (AI) compounds were also identified, with 6,7-bis-methylsulfanyl-5,8-quinolinequinone (18a) exhibiting the highest AI activity (0.11 μM), while 6,7-dichloro-5,8-quinolinequinone (7a), 6,7-dichloro-2-methyl-5,8-quinolinequinone (7b), and 6,7-bis-phenylsulfanyl-quinoline-5,8-diol (19) also exhibited good AI activity and specificity. Several quinolinequinone TB-drug candidates were identified. Of these, 6-amino-7-chloro-5,8-quinolinequinone (11) and 6-amino-7-methanesulfinyl-5,8-quinolinequinone (14), exhibited low MICs (1.56–3.13 μg/mL) for the 100% growth inhibition of M. Bovis BCG. Some general trends pertaining to the functional group substitution of the quinolinequinone core and biological activity were also identified.

We also recommend Trading Suppliers and Manufacturers of 5,8-QUINOLINEQUINONE (cas 10470-83-4). Pls Click Website Link as below: cas 10470-83-4 suppliers

Prev:Mass spectrometry of sulfur-containing derivatives of sugars
Next:Enzymatic and nonenzymatic formation of reactive oxygen species from 6-anilino-5,8-QUINOLINEQUINONE (cas 10470-83-4))